Drug Shortage Report for OXYTOCIN INJECTION, USP
| Report ID | 225346 |
| Drug Identification Number | 02139561 |
| Brand name | OXYTOCIN INJECTION, USP |
| Common or Proper name | OXYTOCIN INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | OXYTOCIN |
| Strength(s) | 10UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10 mL |
| ATC code | H01BB |
| ATC description | POSTERIOR PITUITARY LOBE HORMONES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-04-25 |
| Estimated end date | 2024-05-15 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-26 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our Oxytocin Injection, USP Synthetic 10 USP units/mL MD Vial 10 mL effective April 30, 2024, until May 15, 2024. During this time, our Oxytocin Injection, USP Synthetic 10 USP units/mL SD Vial 1 mL will be available for substitution. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2024-04-26 | English | Compare |
| v2 | 2024-04-17 | French | Compare |
| v1 | 2024-04-17 | English | Compare |
Showing 1 to 3 of 3